240 results If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement. Stibbe advises Jumbo family Van Eerd on acquisition of Hema Stibbe advised Mississippi Ventures, the investment vehicle of the Van Eerd family (owners of supermarket chain Jumbo), on the acquisition of the remaining 50 per cent of the shares in HEMA. Stibbe adviseert Jumbo-familie Van Eerd bij overname HEMA Stibbe heeft Mississippi Ventures, het investeringsvehikel van de familie Van Eerd (eigenaar van supermarktketen Jumbo), geadviseerd bij de overname van de overige 50 procent van de aandelen in HEMA. Stibbe advises Seven2 Stibbe advised Seven2 on the acquisition of a majority stake in Zwart Techniek. Pagination Previous page Page 11 Page 12 Page 13 Current page 14
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.
Stibbe advises Jumbo family Van Eerd on acquisition of Hema Stibbe advised Mississippi Ventures, the investment vehicle of the Van Eerd family (owners of supermarket chain Jumbo), on the acquisition of the remaining 50 per cent of the shares in HEMA.
Stibbe adviseert Jumbo-familie Van Eerd bij overname HEMA Stibbe heeft Mississippi Ventures, het investeringsvehikel van de familie Van Eerd (eigenaar van supermarktketen Jumbo), geadviseerd bij de overname van de overige 50 procent van de aandelen in HEMA.
Stibbe advises Seven2 Stibbe advised Seven2 on the acquisition of a majority stake in Zwart Techniek.